CellSource Co., Ltd. Stock Price

TSE:4880 Community·JP¥7.2b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

4880 Share Price Performance

JP¥0

-796.00 (-100.00%)

JP¥0

-796.00 (-100.00%)

JP¥0

Thu, 5 Mar 26

Share Pricen/a

4880 Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Flawless balance sheet with slight risk.

4 Risks

1 Reward

View Full Analysis

CellSource Co., Ltd. Key Details

Last Reported Earnings

Oct 31, 2025

Next Reporting Earnings

n/a

: 0.50
: 56.24%
: 0.27%
: 0%

View Full Analysis

About 4880

Founded: 2015
Employees: 148
CEO: Masayuki Yamakawa
WebsiteView website: www.cellsource.co.jp

CellSource Co., Ltd. engages in the regenerative medicine-related businesses in Japan. The company provides processing services to extract adipose-derived stem cells from patients’ adipose tissues, and to prepare platelet-rich plasma from patients’ blood; and offers support services for medical facilities providing regenerative medicine therapy. It is also involved in the sale of human stem cell-derived cosmetic ingredients; and Signalift series of anti-aging products, including a serum. The company was incorporated in 2015 and is headquartered in Shibuya, Japan.